Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment - Contacts and Locations

Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment (PROTECT)

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00536172

Locations


United States, Nebraska
	University of Nebraska Medical Center	Recruiting
	Omaha, Nebraska, United States, 68198-5580
	Contact: William J. Burke, MD 402-552-6063 wjburke@unmc.edu
	Contact: Rosella Squires 402-552-6005 rsquires@unmc.edu
	Principal Investigator: William J. Burke, MD

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	William J. Burke, MD	University of Nebraska